VEGFR2/CD309 anticorps (AA 31-130)
Aperçu rapide pour VEGFR2/CD309 anticorps (AA 31-130) (ABIN517318)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 31-130
-
Fonction
- Mouse monoclonal antibody raised against a partial recombinant KDR.
-
Séquence
- LPRLSIQKDI LTIKANTTLQ ITCRGQRDLD WLWPNNQSGS EQRVEVTECS DGLFCKTLTI PKVIGNDTGA YKCFYRETDL ASVIYVYVQD YRSPFIASVS
-
Réactivité croisée
- Humain
-
Attributs du produit
- Antibody Reactive Against Recombinant Protein.
-
Immunogène
- KDR (NP_002244, 31 a.a. ~ 130 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
-
Isotype
- IgG2a
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1x PBS, pH 7.4
-
Conseil sur la manipulation
- Aliquot to avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- KDR
-
Sujet
-
Full Gene Name: kinase insert domain receptor (a type III receptor tyrosine kinase)
Synonyms: CD309,FLK1,VEGFR,VEGFR2 -
ID gène
- 3791
-
NCBI Accession
- NM_002253
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-